04 Jan 2024

Kestra Medical Technologies Surpasses 200 Million Covered Lives for ASSURE Wearable Cardioverter Defibrillator (WCD) System

Additional Health Plans Contract with Kestra Medical Technology Services, Inc., increasing patient access to the ASSURE system as a covered service.

Read More

Newsroom

22 Sep 2023

Kestra Medical Technologies Offers Electrophysiology and Cardiology Clinicians Opportunity to Wear ASSURE WCD System at #HRX2023 Conference

29 Nov 2022

Kestra Medical Technologies Surpasses 100 Million Covered Lives for ASSURE Wearable Cardioverter Defibrillator (WCD) System

11 Apr 2022

ASSURE Wearable Cardioverter Defibrillator (WCD) System Earns 2022 Medical Design Excellence Award

01 Apr 2022

ASSURE Wearable Cardioverter Defibrillator (WCD) System Demonstrates Low False Alarm Rates, High Patient Compliance in Clinical Study

03 Aug 2021

Kestra Medical Technologies Receives FDA Approval for ASSURE Wearable Cardioverter Defibrillator (WCD)

Have Questions?

We’re here to help.